Affini-T Therapeutics is developing T-cell receptor (TCR)-based immunotherapies targeting solid tumors associated with oncogenic mutations such as TP53 R175H and KRAS G12D/G12V. The company aims to enhance the precision of cancer treatment by utilizing specific T-cell therapies to improve patient outcomes in oncology.

Affirm provides point-of-sale installment loans through a digital platform that integrates with retail checkout systems. This service enables consumers to finance purchases over time, addressing the need for flexible payment options in retail transactions.

Airbnb is an online marketplace that links travelers with hosts offering short‑term rentals such as homes, apartments, and unique stays worldwide. The platform handles listing, pricing, payment processing, tax collection, and provides review and insurance features to build trust between guests and hosts.

Anduril provides an autonomous operations platform that fuses data from drones, radar, lidar, satellite and other sensors into a real‑time situational awareness picture. Its edge AI and computer‑vision models detect, classify and track objects autonomously, delivering secure analytics to command interfaces for rapid decision‑making. The solution includes modular autonomous vehicles and a scalable command‑and‑control dashboard, enabling defense agencies to deploy advanced surveillance and reconnaissance capabilities with lower lifecycle costs.

ARTBIO is developing a new class of alpha radioligand therapies that utilize Pb-212 isotopes to target and destroy cancer cells while minimizing damage to healthy tissues. This approach addresses the limitations of existing beta radioligand therapies by offering potentially improved efficacy and safety for patients with solid tumors.

Artera offers a digital health platform that utilizes secure messaging and automated appointment reminders to enhance patient communication. This technology increases patient engagement and adherence to treatment plans, leading to improved health outcomes.

Bitcoin offers a platform for users to buy, sell, spend, swap, and invest in a variety of cryptocurrencies through secure transactions and wallet management. This service addresses the need for accessible and efficient cryptocurrency trading and investment solutions in a rapidly evolving digital economy.

CARGO Therapeutics is developing tri-specific CAR T-cell therapies designed to target and eliminate B-cell lymphoma cells effectively. This approach aims to provide patients with potentially curative treatment options that traditional therapies may not achieve.

Carmot Therapeutics develops next‑generation GLP‑1 and dual GLP‑1/GIP receptor agonists that use biased signaling to minimize β‑arrestin recruitment, reducing receptor desensitization and extending drug activity. Its pipeline includes a once‑weekly injectable (CT‑388), a Phase 2 GLP‑1/GIP candidate for overweight/obesity with type 1 diabetes (CT‑868), and an oral daily GLP‑1 small‑molecule (CT‑996), all aimed at delivering stronger glycemic control, greater weight loss, and improved tolerability for metabolic disease patients.

Carta provides an AI‑enhanced platform that unifies cap table management, fund administration, tax compliance, and portfolio analytics into a single, auditable source of truth for private equity, venture capital, and corporate finance teams. By automating routine workflows such as capital calls, expense reconciliation, and document extraction, the platform improves data accuracy, reduces manual effort, and delivers real‑time insights for faster decision‑making.

Cato Networks provides a single‑vendor, cloud‑native Secure Access Service Edge (SASE) platform that unifies networking, Zero Trust security, and AI‑driven threat protection. The service connects users, sites, and applications over a global private backbone, applying AI‑optimized traffic steering and unified policy management to deliver consistent, high‑performance connectivity and comprehensive security across distributed and multi‑cloud environments.

Cerebras provides a wafer‑scale AI compute platform that runs inference, fine‑tuning, and full‑parameter training of large language models on a single engine, delivering up to 3,000 tokens per second and reducing total cost of ownership versus GPU clusters. The system is offered as on‑premise CS‑2/CS‑3 hardware, private‑cloud capacity, or a pay‑as‑you‑go SaaS, with a drop‑in OpenAI‑compatible API and SOC 2/HIPAA‑certified data handling for enterprise workloads.

Chinook Therapeutics develops targeted therapeutics that focus on addressing significant disease burdens, particularly in kidney diseases. By utilizing advanced biological research and technology, the company aims to enhance patient outcomes and extend life expectancy.

Clasp Therapeutics develops precision immunotherapies using proprietary pHLAre™ T cell engagers that target mutated protein fragments on cancer cells, enabling the immune system to selectively destroy tumors with specific driver mutations. This approach addresses the limitations of current immuno-oncology treatments by expanding therapeutic options for patients with hard-to-treat cancers.

ClickUp offers a cloud‑native workspace that unifies task and project management, collaborative docs, chat, calendars, time tracking, and reporting in a single interface. Its AI‑powered Brain agents enable autonomous task delegation, content creation, and code execution, while low‑code automations and 50+ native integrations streamline workflows with enterprise‑grade security and compliance.

Coinbase is a cryptocurrency exchange and wallet platform that enables users to buy, sell, and securely store digital currencies using blockchain technology. It provides a user-friendly interface for both merchants and consumers, facilitating seamless transactions in the growing digital currency market.

Demandbase offers an AI‑powered go‑to‑market platform that consolidates first‑ and third‑party data to identify in‑market B2B accounts and buying groups, then prioritizes the highest‑impact opportunities. The platform orchestrates coordinated marketing, sales, and advertising programs, automates account‑based experiences, and provides real‑time performance analytics that link activities to pipeline and revenue outcomes.

Doximity provides a HIPAA‑compliant mobile platform that integrates secure voice, video, and text calling with number‑masking, cloud‑based fax, and an AI writing assistant for generating clinical notes, insurance correspondence, and patient education materials. The app also includes encrypted peer‑to‑peer messaging, a curated medical news feed, and a verified clinician directory for U.S. physicians, nurse practitioners, physician assistants, and registered nurses.

Eightfold AI offers a Talent Intelligence Platform that aggregates enterprise-wide people data to create a comprehensive talent network, enabling organizations to understand employee capabilities beyond past experiences. The platform utilizes deep-learning AI to match individuals with suitable opportunities and predict future roles, enhancing talent acquisition and management processes.

Eikon Therapeutics develops a proprietary single-molecule tracking platform that utilizes super-resolution microscopy to measure protein dynamics in living cells, enabling detailed analysis of molecular interactions. This technology addresses the challenge of understanding protein behavior, which is critical for identifying new drug targets and advancing therapeutic development for serious diseases.

Enliven Therapeutics develops small molecule kinase inhibitors that enhance treatment efficacy and safety for cancer patients, specifically targeting resistance mechanisms and brain metastases. The company's therapies aim to improve both survival rates and quality of life for individuals facing cancer.

EToro is a social trading platform that enables users to trade a variety of financial instruments, including currencies, commodities, indices, cryptocurrencies, and stocks, through a user-friendly interface. The platform facilitates peer-to-peer trading and investment strategies, allowing users to leverage the insights and performance of other traders to enhance their investment decisions.

Faire is a wholesale marketplace that connects retailers with over 100,000 brands across various categories, enabling them to source inventory efficiently from a single platform. The platform offers features like free returns on first orders and deferred payment options, addressing the challenges of inventory management and cash flow for small businesses.

Forma.ai offers an AI-powered Sales Performance Management platform that automates the design and execution of sales compensation plans, enabling real-time modeling and optimization of territories and quotas. This solution addresses inefficiencies in traditional sales compensation processes, reducing costs and errors while accelerating planning and deployment by up to 400%.